🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Leronlimab (PRO 140) is a humanized IgG4,k monoclonal antibody (mAb) that r...
Status
Suspended
Location
Hospital Dr Jayme dos Santos Neves
Start Date
2021-10-23
Trial ID
NCT04901689
Treatments Being Tested
The present study will administer the drug leronlimab to 20 participants wh...
Status
Recruiting
Location
Weill Cornell Medicine Brain Health Imaging Institute
Start Date
2026-04-30
Trial ID
NCT07553338
Treatments Being Tested
This is a phase Ib/II Study of Leronlimab (PRO 140) combined with Carboplat...
Status
Terminated
Location
Quest Clinical Research
Start Date
2019-04-22
Trial ID
NCT03838367
This is a Phase 2b/3, multi-center, two part study, designed to evaluate th...
Status
Completed
Location
CD02 Investigational site
Start Date
2015-10
Trial ID
NCT02483078
Treatments Being Tested
This is a single arm, compassionate use study with 30 patients for leronlim...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04313075
Treatments Being Tested
This is a Phase II, Randomized, Double-Blind, Placebo-Controlled, Multi-Cen...
Status
Terminated
Location
University of Miami Sylvester Comprehensive Cancer Center
Start Date
2017-05-14
Trial ID
NCT02737306
This study is a Phase 2b study designed to evaluate the efficacy, safety, a...
Status
Completed
Location
Quest Clinical Research
Start Date
2014-04-16
Trial ID
NCT02175680
Treatments Being Tested
The purpose of this study is: 1. To assess and characterize the PK and PD ...
Status
Completed
Location
Progenics Pharmaceuticals, Inc
Start Date
2007-12
Trial ID
NCT00613379
This is a Phase 2, two-arm, randomized, double blind, placebo controlled mu...
Status
Completed
Location
University of California, Los Angeles
Start Date
2020-04-01
Trial ID
NCT04343651
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of leronlima...
Status
Completed
Location
Arthritis & Rheumatic Disease Specialties
Start Date
2021-03-01
Trial ID
NCT04678830
Treatments Being Tested